Sarcopenia as a Predictor of Future Cognitive Impairment in Older Adults
- PMID: 27102786
- DOI: 10.1007/s12603-015-0613-x
Sarcopenia as a Predictor of Future Cognitive Impairment in Older Adults
Abstract
Objectives: We investigated the association between the indices of sarcopenia and future risk of cognitive impairment in older adults.
Design: Community-based prospective cohort study.
Setting: Community.
Participants: A total of 297 participants aged ≥65 years without cognitive impairment at baseline (mean age, 71.9 ± 6.6 years; men:women, 158:139) and who underwent cognitive evaluation at the 5-year follow-up.
Measurements: Sarcopenia parameters including appendicular lean mass (ALM), handgrip strength, and the Short Physical Performance Battery (SPPB) score at baseline were compared according to the later progression of mild cognitive impairment (MCI) and/or dementia. The operational criteria suggested by the Foundation for the National Institutes of Health Sarcopenia Project were used. We performed multivariate logistic regression analysis to identify the independent indicators of the progression of cognitive impairment.
Results: Among the 297 participants, 242 (81.5%) remained cognitively normal (nonprogression group), whereas 55 (18.5%) showed progression of cognitive impairment (50 subjects (16.8%) to MCI and 5 subjects (1.7%) to dementia) (progression group). Compared with the nonprogression group, subjects in the progression group were older, had a lower educational level, and had lower physical function as assessed by the SPPB; a higher percentage were depressed. Other baseline markers of sarcopenia, including the ALM-to-body mass index ratio and handgrip strength did not differ significantly between the groups. The association between a low SPPB score (<9) and progression of cognitive impairment was maintained after adjustment for conventional risk factors for cognitive impairment (hazard ratio 2.222, 95% confidence interval 1.047-4.716, P = 0.038).
Conclusion: Decreased physical performance, as assessed by the SPPB, but not other markers of sarcopenia, was independently associated with the risk of later cognitive impairment in older adults.
Similar articles
-
Carotid intima-media thickness is associated with the progression of cognitive impairment in older adults.Stroke. 2015 Apr;46(4):1024-30. doi: 10.1161/STROKEAHA.114.008170. Epub 2015 Mar 3. Stroke. 2015. PMID: 25737314
-
Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project).BMJ. 2022 May 11;377:e068788. doi: 10.1136/bmj-2021-068788. BMJ. 2022. PMID: 35545258 Free PMC article. Clinical Trial.
-
Association of nutrition and immune-endocrine dysfunction with muscle mass and performance in cognitively impaired older adults.Arch Gerontol Geriatr. 2018 Mar-Apr;75:20-27. doi: 10.1016/j.archger.2017.11.008. Epub 2017 Nov 16. Arch Gerontol Geriatr. 2018. PMID: 29172062
-
Sarcopenic obesity is associated with cognitive impairment in community-dwelling older adults: The Bunkyo Health Study.Clin Nutr. 2022 May;41(5):1046-1051. doi: 10.1016/j.clnu.2022.03.017. Epub 2022 Mar 16. Clin Nutr. 2022. PMID: 35390728
-
Physical function-derived cut-points for the diagnosis of sarcopenia and dynapenia from the Canadian longitudinal study on aging.J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):985-999. doi: 10.1002/jcsm.12462. Epub 2019 Jul 15. J Cachexia Sarcopenia Muscle. 2019. PMID: 31307126 Free PMC article.
Cited by
-
"Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: a retrospective study".BMC Gastroenterol. 2019 Dec 30;19(1):229. doi: 10.1186/s12876-019-1152-4. BMC Gastroenterol. 2019. PMID: 31888500 Free PMC article.
-
A Cumulative Muscle Index and Its Parameters for Predicting Future Cognitive Decline: Longitudinal Outcomes of the ASPRA Cohort.Int J Environ Res Public Health. 2021 Jul 9;18(14):7350. doi: 10.3390/ijerph18147350. Int J Environ Res Public Health. 2021. PMID: 34299801 Free PMC article.
-
The Link Between Oxysterols and Gut Microbiota in the Co-Dysfunction of Cognition and Muscle.Nutrients. 2025 Apr 6;17(7):1277. doi: 10.3390/nu17071277. Nutrients. 2025. PMID: 40219034 Free PMC article.
-
Sarcopenia and Risk of Cognitive Impairment: Cohort Study and Mendelian Randomization Analysis.JMIR Aging. 2025 Jun 11;8:e66031. doi: 10.2196/66031. JMIR Aging. 2025. PMID: 40499039 Free PMC article.
-
Association between probable sarcopenia and dementia risk: a prospective cohort study with mediation analysis.Transl Psychiatry. 2024 Oct 1;14(1):398. doi: 10.1038/s41398-024-03131-3. Transl Psychiatry. 2024. PMID: 39353910 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources